Global Tissue and Organ Transplantation Market, by Product Type (Tissue Products, Preservation Solution, and Immunosuppressive Drugs), by Application (Organ Transplantation and Tissue Transplantation ), by End User (Hospital, Transplant Centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), is estimated to be valued at US$ 13.9 Billion in 2020 and is expected to exhibit a CAGR of 9.1% during the forecast period (2020-2027), as highlighted in a new report published by Coherent Market Insights.
High prevalence of chronic diseases such as diabetes, cancer, cardiovascular diseases, and renal diseases is expected to drive the market growth during the forecast period. For instance, according to the Centers for Disease Control and Prevention (CDC), 15% of adults in the U.S., accounting for 37 million people suffered from chronic kidney disease in 2019.
For instance, according to the World Health Organization, each year around 17.9 million people worldwide die due to Cardiovascular Diseases.
Tissue and Organ Transplantation Market - Impact of Coronavirus (Covid-19) Pandemic
Since December 2019, the novel coronavirus has spread throughout China and the world, with confirmed cases increasing within a short period of time. Moreover, the incidence and impact of coronavirus disease 2019 (COVID-19) has varied enormously across the globe. The pandemic has negatively impacted organ donation and transplantation in countries that have experienced high rates of infection, including the U.S., France, and the U.K., all reporting >50% reductions in transplant activity.
The coronavirus disease has badly affected ailing patients who are in need of organ transplants. The organ transplantation programme was temporarily suspended during the lockdown as a measure to avert the spread of COVID-19.
Patients with end-stage diseases- kidney, liver, heart, and lung failure, are worried following the COVID 19 pandemic. Although kidney failure patients can improve their health condition with continued dialysis, they are at a slightly higher risk of contracting COVID-19.
Browse 35 Market Data Tables and 31 Figures spread through 220 Pages and in-depth TOC on Tissue and Organ Transplantation Market, by Product Type (Tissue Products Preservation Solution, and Immunosuppressive Drugs), by Application (Organ Transplantation and Tissue Transplantation ), by End User (Hospital, Transplant Centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), - Forecast to 2027"
To know the latest trends and insights related to tissue and organ transplantation market, click the link below:
https://www.coherentmarketinsights.com/market-insight/tissue-and-organ-transplantation-market-4342
Key Takeaways of the Tissue and Organ Transplantation Market:
- The global tissue and organ transplantation market is expected to exhibit a CAGR of 9.1% during the forecast period (2020-2027), owing to increasing prevalence of diseases such as diabetes, cancer, cardiovascular diseases, renal diseases, and Alzheimer’s disease
- Major players operating in the global tissue and organ transplantation market include CryoLife, Inc., Folio Biosciences, Arthrex, Abbvie, Inc., Zimmer Biomet, Medtronic PLC, Novartis AG, Stryker Corporation, BiolifeSolutions, Inc., Teva Pharmaceuticals, and Veloxis Pharmaceutical.
